IBDEI04V ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1754,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,1754,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,1755,0)
 ;;=Z85.830^^3^51^20
 ;;^UTILITY(U,$J,358.3,1755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1755,1,3,0)
 ;;=3^Personal history of malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,1755,1,4,0)
 ;;=4^Z85.830
 ;;^UTILITY(U,$J,358.3,1755,2)
 ;;=^5063444
 ;;^UTILITY(U,$J,358.3,1756,0)
 ;;=Z85.828^^3^51^21
 ;;^UTILITY(U,$J,358.3,1756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1756,1,3,0)
 ;;=3^Personal history of malignant neoplasm of skin NEC
 ;;^UTILITY(U,$J,358.3,1756,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,1756,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,1757,0)
 ;;=Z85.841^^3^51^22
 ;;^UTILITY(U,$J,358.3,1757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1757,1,3,0)
 ;;=3^Personal history of malignant neoplasm of brain
 ;;^UTILITY(U,$J,358.3,1757,1,4,0)
 ;;=4^Z85.841
 ;;^UTILITY(U,$J,358.3,1757,2)
 ;;=^5063447
 ;;^UTILITY(U,$J,358.3,1758,0)
 ;;=Z85.848^^3^51^23
 ;;^UTILITY(U,$J,358.3,1758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1758,1,3,0)
 ;;=3^Personal history of malignant neoplasm of prt nervous tissue
 ;;^UTILITY(U,$J,358.3,1758,1,4,0)
 ;;=4^Z85.848
 ;;^UTILITY(U,$J,358.3,1758,2)
 ;;=^5063448
 ;;^UTILITY(U,$J,358.3,1759,0)
 ;;=Z85.850^^3^51^24
 ;;^UTILITY(U,$J,358.3,1759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1759,1,3,0)
 ;;=3^Personal history of malignant neoplasm of thyroid
 ;;^UTILITY(U,$J,358.3,1759,1,4,0)
 ;;=4^Z85.850
 ;;^UTILITY(U,$J,358.3,1759,2)
 ;;=^5063449
 ;;^UTILITY(U,$J,358.3,1760,0)
 ;;=Z85.858^^3^51^25
 ;;^UTILITY(U,$J,358.3,1760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1760,1,3,0)
 ;;=3^Personal history of malignant neoplasm of endocrine glands
 ;;^UTILITY(U,$J,358.3,1760,1,4,0)
 ;;=4^Z85.858
 ;;^UTILITY(U,$J,358.3,1760,2)
 ;;=^5063450
 ;;^UTILITY(U,$J,358.3,1761,0)
 ;;=Z86.61^^3^51^5
 ;;^UTILITY(U,$J,358.3,1761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1761,1,3,0)
 ;;=3^Personal history of infections of the central nervous system
 ;;^UTILITY(U,$J,358.3,1761,1,4,0)
 ;;=4^Z86.61
 ;;^UTILITY(U,$J,358.3,1761,2)
 ;;=^5063472
 ;;^UTILITY(U,$J,358.3,1762,0)
 ;;=Z87.09^^3^51^4
 ;;^UTILITY(U,$J,358.3,1762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1762,1,3,0)
 ;;=3^Personal history of diseases of the respiratory system NEC
 ;;^UTILITY(U,$J,358.3,1762,1,4,0)
 ;;=4^Z87.09
 ;;^UTILITY(U,$J,358.3,1762,2)
 ;;=^5063481
 ;;^UTILITY(U,$J,358.3,1763,0)
 ;;=Z87.01^^3^51^27
 ;;^UTILITY(U,$J,358.3,1763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1763,1,3,0)
 ;;=3^Personal history of pneumonia (recurrent)
 ;;^UTILITY(U,$J,358.3,1763,1,4,0)
 ;;=4^Z87.01
 ;;^UTILITY(U,$J,358.3,1763,2)
 ;;=^5063480
 ;;^UTILITY(U,$J,358.3,1764,0)
 ;;=Z86.010^^3^51^3
 ;;^UTILITY(U,$J,358.3,1764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1764,1,3,0)
 ;;=3^Personal history of colonic polyps
 ;;^UTILITY(U,$J,358.3,1764,1,4,0)
 ;;=4^Z86.010
 ;;^UTILITY(U,$J,358.3,1764,2)
 ;;=^5063456
 ;;^UTILITY(U,$J,358.3,1765,0)
 ;;=Z87.440^^3^51^28
 ;;^UTILITY(U,$J,358.3,1765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1765,1,3,0)
 ;;=3^Personal history of urinary (tract) infections
 ;;^UTILITY(U,$J,358.3,1765,1,4,0)
 ;;=4^Z87.440
 ;;^UTILITY(U,$J,358.3,1765,2)
 ;;=^5063495
 ;;^UTILITY(U,$J,358.3,1766,0)
 ;;=Z87.441^^3^51^26
 ;;^UTILITY(U,$J,358.3,1766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1766,1,3,0)
 ;;=3^Personal history of nephrotic syndrome
 ;;^UTILITY(U,$J,358.3,1766,1,4,0)
 ;;=4^Z87.441
 ;;^UTILITY(U,$J,358.3,1766,2)
 ;;=^5063496
 ;;^UTILITY(U,$J,358.3,1767,0)
 ;;=Z91.81^^3^51^1
 ;;
 ;;$END ROU IBDEI04V
